Results 141 to 150 of about 2,383,058 (360)

The needs, preferences, and experiences of LGBT + people living with dementia: a systematic review with thematic synthesis

BMC Geriatrics
Background LGBT + people are disproportionately at an increased risk for developing dementia. Dementia can compound the impact of stigma and social marginalisation experienced by LGBT + people, and is likely to create barriers to accessing healthcare ...
Claude Chidiac, Catherine Walshe, Jane Lowers, Nancy Preston   +3 more
doaj   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Investigating experiences of people with advanced breast or lung cancer in their natural context: protocol for an experience sampling study

BMJ Open
Introduction People with advanced cancer can experience a wide range of multidimensional symptoms or concerns, but little is known about when and how these fluctuate in daily life.
Lieve Van den Block, Kim de Nooijer, Lara Pivodic, Geert Crombez, Eline Naert, Joran Geeraerts, Mark De Ridder   +6 more
doaj   +1 more source

MOESM1 of The impact of population ageing on end-of-life care in Scotland: projections of place of death and recommendations for future service provision

, 2019
Anne Finucane, Anna E Bone, Catherine Evans, Bárbara Gomes, Richard Meade, Irene J Higginson, Scott A Murray   +6 more
openalex   +1 more source

Belgian temporary workers at end of working life: an intersectional lifecourse analysis [PDF]

, 2018
Nathalie Burnay
openalex   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Do cancer patients with dementia receive less aggressive treatment in end-of-life care? A nationwide population-based cohort study

, 2017
Huei‐Kai Huang, Jyh‐Gang Hsieh, Chia‐Jung Hsieh, Yingwei Wang   +3 more
openalex   +2 more sources

Use of Antimicrobials at the End of Life (EOL): A Retrospective Cohort Study Analyzing Providers’ Reasons for Prescribing Antimicrobials at the EOL—Their Benefits and Adverse Effects (S766) [PDF]

, 2020
Pooja Vyas, Santiago Lopez
openalex   +1 more source

P-172 Development of a sepsis screening tool for end-of-life care [PDF]

, 2023
C. D. Cook, Ron Daniels
openalex   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source